Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals
Authors
Keywords
DAA-experienced, NS5B polymerase inhibitor, NS5A inhibitor, Antiviral resistance, Salvage therapy
Journal
Hepatology International
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-07-20
DOI
10.1007/s12072-018-9878-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nonstructural protein 5A/P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection
- (2018) Akira Doi et al. HEPATOLOGY
- Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen
- (2017) Edward J. Gane et al. HEPATOLOGY
- Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study
- (2017) Yoshiiku Kawakami et al. JOURNAL OF GASTROENTEROLOGY
- Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapy
- (2017) Goki Suda et al. JOURNAL OF GASTROENTEROLOGY
- Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection
- (2017) Hiromitsu Kumada et al. JOURNAL OF GASTROENTEROLOGY
- Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses
- (2017) Tania M. Welzel et al. JOURNAL OF HEPATOLOGY
- Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b, who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literature
- (2017) Yuki Haga et al. Oncotarget
- Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1
- (2016) Etsuko Iio et al. JOURNAL OF GASTROENTEROLOGY
- Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment Failure
- (2016) Jun Itakura et al. PLoS One
- O005 : Retreatment of patients who failed 8 or 12 weeks of ledipasvir/sofosbuvir-based regimens with ledipasvir/sofosbuvir for 24 weeks
- (2015) E. Lawitz et al. JOURNAL OF HEPATOLOGY
- Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
- (2015) Graham R. Foster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
- (2015) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy
- (2015) Kazuaki Chayama et al. Viruses-Basel
- Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection
- (2014) Hiromitsu Kumada et al. HEPATOLOGY
- Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial
- (2014) Masao Omata et al. JOURNAL OF VIRAL HEPATITIS
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changing Trends in Hepatitis C Infection over the Past 50 Years in Japan
- (2010) Hobyung Chung et al. INTERVIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search